Details for Patent: 11,617,758
✉ Email this page to a colleague
Which drugs does patent 11,617,758 protect, and when does it expire?
Patent 11,617,758 protects KYZATREX and is included in one NDA.
This patent has twenty patent family members in eleven countries.
Drugs Protected by US Patent 11,617,758
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-001 | Jul 27, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING TESTOSTERONE DEFICIENCY | ⤷ Sign Up | |||
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING TESTOSTERONE DEFICIENCY | ⤷ Sign Up | |||
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-003 | Jul 27, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING TESTOSTERONE DEFICIENCY | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,617,758
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2822435 | ⤷ Sign Up | |||
China | 105188670 | ⤷ Sign Up | |||
European Patent Office | 2519230 | ⤷ Sign Up | |||
European Patent Office | 2682111 | ⤷ Sign Up | |||
European Patent Office | 2968137 | ⤷ Sign Up | |||
Spain | 2710149 | ⤷ Sign Up | |||
Spain | 2907284 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |